JANE STREET GROUP, LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$183,705
+470.6%
191,359
+345.8%
0.00%
Q1 2023$32,196
-64.9%
42,928
-82.8%
0.00%
Q4 2022$91,809
+216.6%
249,141
+267.9%
0.00%
Q3 2022$29,000
+70.6%
67,722
+220.1%
0.00%
Q2 2022$17,000
-74.6%
21,157
-58.9%
0.00%
Q1 2022$67,000
-88.1%
51,504
-88.3%
0.00%
Q4 2021$561,000
+82.1%
442,004
+213.4%
0.00%
Q3 2021$308,000
+51.7%
141,046
+159.2%
0.00%
Q2 2021$203,000
+103.0%
54,406
+87.3%
0.00%
Q4 2020$100,000
-31.0%
29,040
-18.6%
0.00%
Q3 2020$145,000
-12.7%
35,691
-27.2%
0.00%
Q2 2020$166,000
+435.5%
49,015
+276.0%
0.00%
Q1 2020$31,000
-94.0%
13,036
-90.9%
0.00%
-100.0%
Q4 2019$520,000
+161.3%
143,000
+668.3%
0.00%
Q1 2019$199,000
-32.3%
18,612
+6.5%
0.00%
-100.0%
Q3 2018$294,000
+19.5%
17,481
+14.1%
0.00%0.0%
Q1 2018$246,000
+61.8%
15,315
+42.1%
0.00%
Q3 2017$152,000
+7.8%
10,774
-49.8%
0.00%
-100.0%
Q2 2016$141,000
-39.2%
21,475
-41.0%
0.00%0.0%
Q1 2016$232,000
+186.4%
36,406
+169.8%
0.00%0.0%
Q4 2015$81,000
-91.4%
13,496
-88.3%
0.00%
-91.7%
Q2 2014$939,000
+552.1%
115,551
+528.1%
0.01%
+500.0%
Q1 2014$144,00018,3980.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders